MeSH tree: C18.452.104.579.610
Postmenopausal osteoporosis is a condition that weakens bones, making them brittle and prone to fracture. Taking the hormone estradiol can reverse these effects, but it may also increase endometrial and uterine cancer risks. ...
Nov 18, 2025
0
26
As we age, our bones lose density and become more fragile, putting us in danger of breaks and fractures. This is especially a concern among post-menopausal women who generally have much greater losses in bone density than ...
Sep 17, 2024
0
39
Bisphosphonates are the recommended first-line treatment in post-menopausal osteoporosis, with denosumab recommended second-line. Based on the length of clinical trials for bisphosphonates, these drugs are usually prescribed ...
Jun 12, 2024
0
36
As pickleball has gained in popularity, associated fractures have skyrocketed 90-fold since 2002, according to a study presented at the 2024 Annual Meeting of the American Academy of Orthopedic Surgeons, held from Feb. 12 ...
Feb 19, 2024
0
38
New research published in The FASEB Journal indicates that increasing the expression of a particular gene may help to prevent bone loss associated with postmenopausal osteoporosis.
Aug 9, 2023
0
52
As the population continues to age, there is greater focus on bone health and minimizing fractures to maintain mobility. A new study suggests that various types of hormone therapies not only increase lumbar spine bone mineral ...
May 8, 2023
0
63
A new model, described today in eLife, may help improve outcomes for patients with postmenopausal osteoporosis and reduce the risks of side effects by helping physicians build more personalized treatment regimes.
Aug 9, 2022
0
115
